- EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy
-
Minhye Kim, Ji Min Na, Gyeong-Won Lee, Seung Jun Lee, Jong Duk Kim, Jung Wook Yang
-
J Pathol Transl Med. 2021;55(1):79-82. Published online December 3, 2020
-
DOI: https://doi.org/10.4132/jptm.2020.11.02
-
-
2,389
View
-
94
Download
-
1
Citations
-
 PDF
-
Citations
Citations to this article as recorded by  - RET Proto-Oncogene—Not Such an Obvious Starting Point in Cancer Therapy
Tomasz Kucharczyk, Paweł Krawczyk, Dariusz M. Kowalski, Adam Płużański, Tomasz Kubiatowski, Ewa Kalinka
Cancers.2022; 14(21): 5298. CrossRef
|
